Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.22.2.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities

These following common stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:

 

                 
   

June 30,

2022

(Unaudited)

   

June 30,

2021
(Unaudited)

 
Options to purchase common stock     302,500       -  
Warrants to purchase common stock     2,337,274       2,365,473  
Unvested restricted common stock    

488,429

      -  
Convertible Series C Preferred Stock    

-

     

7

 
Total anti-dilutive securities    

3,128,203

      2,365,480